Abstract
The ZR-75-1 ER positive breast cancer cell line,xenografted in female nude mice, has been usedto determine the effect of tamoxifen on cellproliferation (as measured by mitosis) and cell death(as evidenced by apoptosis and necrosis). After 2days treatment, there was a significant rise inapoptosis (p < 0.05), whereas a fall inmitosis was not apparent until 7 days (p< 0.05). Furthermore there was an increase inthe apoptotic : mitotic ratio on day 7(p < 0.05). These changes antedated tumour regression,which did reach not significance until day 14.Tamoxifen did not increase necrosis (which significantly decreasedin treated tumours once they had regressed (p< 0.01)). In contrast tamoxifen treatment of xenograftedMDA-MB-231 ER-negative breast cancer cells produced no significanteffects on growth, apoptosis, or mitosis. This studypresents clear evidence for tamoxifen inducing apoptosis inZR-75-1 xenografts (but not MDA-MB-231 tumours). Since changesin apoptosis and mitosis antedate tumour regression, theirassessment may provide the potential by which topredict tumour response to tamoxifen therapy.
Similar content being viewed by others
References
Wolf DM, Fuqua SAW: Mechanisms of action of antiestrogens. Cancer Treat Rev 21: 247–271, 1995
Allan SG, Rodger A, Smyth JF, Leonard RCF, Chetty U, Forrest APM: Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. Br Med J 290: 358–358, 1985
Gazet J-C, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J, Lowndes S: Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol 20: 207–214, 1994
Gaskell DJ, Hawkins RA, de Carteret S, Chetty U, Sangster K, Forrest APM: Indications for primary tamoxifen therapy in elderly women with breast cancer. Br J Surg 79: 1317–1320, 1992
Schwartzman RA, Cidlowski JA: Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine Rev 14: 133–151, 1993
Osborne CK, Boldt CH, Clark GM, Trent JM: Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43: 3583–3585, 1983
Brunner N, Bronzert D, Vindeløv LL, Rygaard K, Spang-Thomsen M, Lippman ME: Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 49: 1515–1520, 1989
Kyprianou N, English HF, Davidson NE, Isaacs JT: Programmed cell death during regression of MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162–166, 1991
Warri AM, Huovinen RL, Martikainen PM, Härkönen PL: Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85: 1412–1418, 1993
Brugal G, Dye R, Krief B, Chassery J-M, Tanke H, Tucker JH: HOME: Highly Optimized Microscope Environment. Cytometry 13: 109–116, 1992
Cohen JJ: Apoptosis. Immunol Today 14: 126–130, 1993
van Diest PJ, Baak JPA, Matze-Cok P, Wisse-Brekelmans ECM, van Galen CM, Kurver PHJ, Bellot SM, Fijnheer J, van Gorp LHM, Kwee WS, Los J, Peterse JL, Ruitenberg HM, Schapers RFM, Schipper MEI, Somsen JG, Willig WPM, Ariens ATh: Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the multicenter morphometric mammary carcinoma project. Hum Pathol 23: 603–607, 1992
Arends MJ, McGregor AH, Wyllie AH: Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras and HPV oncogenes. Am J Pathol 144: 1045–1057, 1994
Bland JM, Altman DG: Measurement error. Br Med J 313: 744–744, 1996
Steel CG: Growth kinetics of tumours. Clarendon Press, Oxford, 1977, p 21.
Tominaga T, Yoshida Y, Matsumoto A, Hayashi K, Kosaki G: Effects of tamoxifen and the derivative (tat) on cell-cycle of MCF-7 in vitro. Anticancer Res 13: 661–666, 1993
Sarkaria JN, Gibson DFC, Jordan VC, Fowler JF, Lindstrom MJ, Mulcahy RT: Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labelling and flow cytometry. Cancer Res 530: 4413–4417, 1993
Wang TTY, Phang JM: Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487–2489, 1995
Kristensen CA, Kristjansen PEG, Brünner N, Quistorff B, Spang-Thomsen M: Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity and apoptotic index. Cancer Res 55: 4146–4150, 1995
Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257, 1972
Wijsman JH, Cornelisse CJ, Keijzer R, van de Velde CJH, Elvers B, van Dierendonck JH: Effect of hormone depletion on cell survival in the EMR-86 rat mamary carcinoma. Br J Cancer 73: 1210–1215, 1996
Gold R, Schmeid M, Giegerich G, Breischopf H, Hartung HP, Toyka KV: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71: 219–225, 1994
Gagliardi A, Collins DC: Inhibition of angiogenesis by antioestrogens. Cancer Res 530: 533–535, 1993
Haran EF, Maretzek AF, Goldberg I, Degani H: Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res 549: 5511–5514, 1994
Dowsett M, Johnston SRD, Newby J, Golding M, Sacks N, Smith IE: Mechanisms of hormone response: a role for apoptosis. Endocrine-Related Cancer 2: 3–11, 1995
Gorczyca W, Tuziak T, Kram A, Melamed MR, Darzynkiewicz Z: Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labelling of fragmented DNA. Cytometry 15: 169–175, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cameron, D., Ritchie, A., Langdon, S. et al. Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression. Breast Cancer Res Treat 45, 99–107 (1997). https://doi.org/10.1023/A:1005850827825
Issue Date:
DOI: https://doi.org/10.1023/A:1005850827825